LS, G., MC, H., E, S., A, G., MT, S., CC, P., . . . EY, Y. (2023). Clinical, pathologic, and molecular features of amphicrine prostate cancer. The Prostate, 83(7), 641. https://doi.org/10.1002/pros.24497
Chicago Style (17th ed.) CitationLS, Graham, Haffner MC, Sayar E, Gawne A, Schweizer MT, Pritchard CC, Coleman I, Nelson PS, and Yu EY. "Clinical, Pathologic, and Molecular Features of Amphicrine Prostate Cancer." The Prostate 83, no. 7 (2023): 641. https://doi.org/10.1002/pros.24497.
MLA (9th ed.) CitationLS, Graham, et al. "Clinical, Pathologic, and Molecular Features of Amphicrine Prostate Cancer." The Prostate, vol. 83, no. 7, 2023, p. 641, https://doi.org/10.1002/pros.24497.
Warning: These citations may not always be 100% accurate.